Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Diseases”

339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 339 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07642050
What this trial is testing

Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Biohaven Therapeutics Ltd. 420
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Large-scale testing (Phase 3)Study completedNCT03614234
What this trial is testing

Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 29
Not applicableWithdrawnNCT04598516
What this trial is testing

Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30

Who this might be right for
Acute Kidney Injury (Nontraumatic)Contrast-induced NephropathyRenal Insufficiency
Maastricht University Medical Center
Not applicableEnded earlyNCT00399256
What this trial is testing

Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn

Who this might be right for
Chronic Kidney Failure
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) 60
Not applicableStudy completedNCT00324675
What this trial is testing

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Who this might be right for
Type 2 DiabetesOvert Diabetic Nephropathy
Technische Universität Dresden 28
Not applicableLooking for participantsNCT07246265
What this trial is testing

Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care

Who this might be right for
Sickle Cell DiseaseGlomerular HyperfiltrationSickle Cell Nephropathy+2 more
University Hospital, Tours 100
Post-approval studies (Phase 4)Study completedNCT00498368
What this trial is testing

Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Mayo Clinic 34
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Not applicableStudy completedNCT01766687
What this trial is testing

Impact of Increased Water Intake in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 822
Not applicableStudy completedNCT01684722
What this trial is testing

Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease

Who this might be right for
Diabetes
University of Washington 1,312
Testing effectiveness (Phase 2)Looking for participantsNCT00977977
What this trial is testing

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Who this might be right for
Nephrotic SyndromeProteinuriaAutoimmune Disease+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Post-approval studies (Phase 4)Ended earlyNCT01129557
What this trial is testing

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Who this might be right for
Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive Nephrosclerosis+4 more
Columbia University 46
Post-approval studies (Phase 4)Ended earlyNCT00830037
What this trial is testing

A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseIron-deficiency Anemia
Indiana University 136
Testing effectiveness (Phase 2)Study completedNCT05065970
What this trial is testing

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Who this might be right for
Immunoglobulin A (IgA) Nephropathy
HI-Bio, A Biogen Company 54
Not applicableWithdrawnNCT00134797
What this trial is testing

Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists

Who this might be right for
Chronic Kidney Disease
United States Naval Medical Center, San Diego
Testing effectiveness (Phase 2)Ended earlyNCT01572610
What this trial is testing

A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 11
Testing effectiveness (Phase 2)Study completedNCT03878277
What this trial is testing

Evaluation of Coffee Therapy for Improvement of Renal Oxygenation

Who this might be right for
Type1diabetesType1 Diabetes MellitusDiabetic Kidney Disease+4 more
University of Colorado, Denver 10
Not applicableNot Yet RecruitingNCT07598448
What this trial is testing

Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

Who this might be right for
Complement 3 Glomerulopathy
Novartis Pharmaceuticals 35
Load More Results